vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Coca-Cola Consolidated, Inc. (COKE). Click either name above to swap in a different company.
Coca-Cola Consolidated, Inc. is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× BioNTech SE). Coca-Cola Consolidated, Inc. runs the higher net margin — 7.2% vs -1.9%, a 9.1% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Coca-Cola Consolidated, Inc., headquartered in Charlotte, North Carolina, is the largest independent Coca-Cola bottler in the United States.
BNTX vs COKE — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.9B |
| Net Profit | $-28.7M | $137.3M |
| Gross Margin | — | 39.6% |
| Operating Margin | -3.1% | 12.7% |
| Net Margin | -1.9% | 7.2% |
| Revenue YoY | — | 9.0% |
| Net Profit YoY | — | -23.3% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.9B | ||
| Q3 25 | $1.5B | $1.9B | ||
| Q2 25 | $260.8M | $1.9B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | — | $137.3M | ||
| Q3 25 | $-28.7M | $142.3M | ||
| Q2 25 | $-386.6M | $187.4M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | — | $178.9M | ||
| Q3 24 | $198.1M | $115.6M | ||
| Q2 24 | — | $172.8M | ||
| Q1 24 | — | $165.7M |
| Q4 25 | — | 39.6% | ||
| Q3 25 | — | 39.6% | ||
| Q2 25 | — | 40.0% | ||
| Q1 25 | — | 39.7% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 39.5% | ||
| Q2 24 | — | 39.9% | ||
| Q1 24 | — | 40.2% |
| Q4 25 | — | 12.7% | ||
| Q3 25 | -3.1% | 13.1% | ||
| Q2 25 | -192.1% | 14.7% | ||
| Q1 25 | — | 12.0% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | 0.8% | 12.9% | ||
| Q2 24 | — | 14.4% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 7.2% | ||
| Q3 25 | -1.9% | 7.5% | ||
| Q2 25 | -148.2% | 10.1% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | 10.2% | ||
| Q3 24 | 15.9% | 6.5% | ||
| Q2 24 | — | 9.6% | ||
| Q1 24 | — | 10.4% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $281.9M |
| Total DebtLower is stronger | — | $2.8B |
| Stockholders' EquityBook value | — | $-739.7M |
| Total Assets | — | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $281.9M | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $401.3M |
| Q4 25 | — | $2.8B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $599.3M |
| Q4 25 | — | $-739.7M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $5.5B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.3B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $4.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | 1.49× | ||
| Q1 24 | — | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $209.0M |
| Free Cash FlowOCF − Capex | — | $106.7M |
| FCF MarginFCF / Revenue | — | 5.6% |
| Capex IntensityCapex / Revenue | — | 5.4% |
| Cash ConversionOCF / Net Profit | — | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $619.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $209.0M | ||
| Q3 25 | — | $316.7M | ||
| Q2 25 | — | $208.1M | ||
| Q1 25 | — | $198.2M | ||
| Q4 24 | — | $168.5M | ||
| Q3 24 | — | $270.8M | ||
| Q2 24 | — | $242.9M | ||
| Q1 24 | — | $194.3M |
| Q4 25 | — | $106.7M | ||
| Q3 25 | — | $264.1M | ||
| Q2 25 | — | $148.5M | ||
| Q1 25 | — | $100.3M | ||
| Q4 24 | — | $84.8M | ||
| Q3 24 | — | $142.8M | ||
| Q2 24 | — | $160.5M | ||
| Q1 24 | — | $117.2M |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 14.0% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | — | 1.52× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 2.34× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 1.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNTX
Segment breakdown not available.
COKE
| Transferred At Point In Time | $1.9B | 99% |
| Transferred Over Time | $15.1M | 1% |
